MarketPeel
Insider Trading Intelligence
GB

Gary Blackford

AVNS
DIRECTOR · AVANOS MEDICAL, INC. · CIK 0001156320
FILING MIX · LIFETIME100%/0%
BUYS
11
SELLS
0
TOTAL VALUE
$946.8K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
12,003
AVG SELL PX
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Gary Blackford, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%-0.46%-1.58%+1.12%+1.12%
14d4+100.00%+5.35%+0.65%+4.70%+4.70%
30d4+100.00%+17.11%+6.23%+10.87%+10.87%
60d4+100.00%+2.89%+5.30%-2.40%-2.40%
90d4+100.00%+9.18%+10.37%-1.19%-1.19%
180d4+100.00%+38.42%+13.04%+25.39%+25.39%
1y4(2 pending)+100.00%+46.46%+46.67%-0.21%-0.21%
2y4(2 pending)+0.00%-8.54%+40.17%-48.72%-48.72%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AVNS · 12,003 shares · as of May 8, 2026
022,89845,79768,69591,593202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 0 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
12,00312,003May 8, 2026May 12, 2026View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
20,000$10.98$219.5K91,593Aug 13, 2025Aug 15, 2025View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
40,000$11.00$439.8K40,000Aug 13, 2025Aug 15, 2025View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
12,00371,593Jan 2, 2025Jan 6, 2025View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
8,37859,590Jan 3, 2024Jan 4, 2024View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
7,00851,212Jan 3, 2023Jan 5, 2023View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
5,35444,204Jan 3, 2022Jan 4, 2022View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
4,00538,850Jan 4, 2021Jan 6, 2021View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
5,000$28.50$142.5K34,845May 8, 2020May 11, 2020View →
AVNS
AVANOS MEDICAL, INC.
PURCHASE
5,000$29.00$145.0K29,845May 8, 2020May 11, 2020View →
AVNS
AVANOS MEDICAL, INC.
PURCHASEGRANT
Stock grant
5,29324,845Jan 2, 2020Jan 8, 2020View →
Other insiders · AVNS
Loading peer insiders…
About this filer
CIK 0001156320
ROLE
Director
PRIMARY
AVNS
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001156320DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback